Immunomodulators for Skin Cancer
September 2004 | Volume 3 | Issue 5 | Original Article | 533 | Copyright © September 2004
Adriana M Villa and MD, Brian Berman MD PhD
AbstractTherapeutic interventions to augment tumor antigenicity or increase the hostâ€™s immune response against cancer cells include recombinant cytokines, immune modulators, vaccination with tumor antigens, T cell-based immunotherapy, and gene therapy. We describe the current role of the immunomodulators (up-regulators of the immune response) in the therapy of skin cancer (non melanoma skin cancer, melanoma, lymphoma, Kaposi sarcoma, and extramammary Pagetâ€™s disease).